Literature DB >> 22430646

Increased B7-H1 expression on peripheral blood T cells in oral lichen planus correlated with disease severity.

Gang Zhou1, Jing Zhang, Xiang-wei Ren, Jing-yu Hu, Ge-fei Du, Xue-yi Xu.   

Abstract

BACKGROUND: Oral lichen planus (OLP) is a chronic and T cell-mediated autoimmune disease whose immunopathogenesis may involve antigen-presentation, T cells activation and migration as well as keratinocytes apoptosis. PD-1/B7-H1 pathway may have a unique function in regulating self-reactive T cells associated with inflammatory response and maintaining tolerance in peripheral tissues. In this study, we aimed to explore the contribution of PD-1/B7-H1 pathway to OLP.
METHODS: We determined the expression of PD-1 and B7-H1 on peripheral blood T cells from OLP cases and analyzed their association with disease severity assessed by RAE (reticular, atrophic and erosive lesion) scoring system. In addition, interferon-γ, interleukin (IL)-2, IL-4, IL-10 and soluble PD-1 concentrations in serum were measured using ELISA. Then, we explored the regulation of PD-1/B7-H1 pathway on T cells immune response in OLP by blockade of PD-1 or B7-H1.
RESULTS: We found that PD-1 and B7-H1 were up-regulated on peripheral blood T cells from OLP patients and B7-H1 expression positively correlated with disease severity of OLP. It is suggested that Th1 dominant inflammatory situation might contribute to the high expression of PD-1 and B7-H1 in OLP. Blockade of PD-1/B7-H1 pathway significantly increased the proliferation, and IFN-γ and IL-2 production of T cells.
CONCLUSIONS: PD-1/B7-H1 pathway may play an important role in negatively modulating T cell-mediated immune response in OLP, and provide the rationale to employ B7-H1 expression on peripheral blood T cells as a marker of severity of OLP and to develop agonists targeting PD-1/B7-H1 pathway as a promising immunotherapeutic strategy for OLP.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22430646     DOI: 10.1007/s10875-012-9683-2

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  29 in total

Review 1.  Oral lichen planus.

Authors:  P B Sugerman; N W Savage; X Zhou; L J Walsh; M Bigby
Journal:  Clin Dermatol       Date:  2000 Sep-Oct       Impact factor: 3.541

2.  PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells.

Authors:  P'ng Loke; James P Allison
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-15       Impact factor: 11.205

3.  Oral lichen planus: a clinical and morphometric study of oral lesions in relation to clinical presentation.

Authors:  Juan Seoane; María Amparo Romero; Pablo Varela-Centelles; Pedro Diz-Dios; María José Garcia-Pola
Journal:  Braz Dent J       Date:  2004-08-16

Review 4.  Immunoregulatory role of B7-H1 in chronicity of inflammatory responses.

Authors:  Haidong Dong; Xianming Chen
Journal:  Cell Mol Immunol       Date:  2006-06       Impact factor: 11.530

Review 5.  The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection.

Authors:  Arlene H Sharpe; E John Wherry; Rafi Ahmed; Gordon J Freeman
Journal:  Nat Immunol       Date:  2007-03       Impact factor: 25.606

6.  Scoring system for monitoring oral lichenoid lesions: a preliminary study.

Authors:  Siribang-On Piboonniyom; Nathaniel Treister; Waranuch Pitiphat; Sook-Bin Woo
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2005-06

Review 7.  Management of oral lichen planus.

Authors:  C Scully; D Eisen; M Carrozzo
Journal:  Am J Clin Dermatol       Date:  2000 Sep-Oct       Impact factor: 7.403

8.  Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.

Authors:  R Houston Thompson; Susan M Kuntz; Bradley C Leibovich; Haidong Dong; Christine M Lohse; W Scott Webster; Shomik Sengupta; Igor Frank; Alexander S Parker; Horst Zincke; Michael L Blute; Thomas J Sebo; John C Cheville; Eugene D Kwon
Journal:  Cancer Res       Date:  2006-04-01       Impact factor: 12.701

9.  Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance.

Authors:  Changping Wu; Yibei Zhu; Jingting Jiang; Jiemin Zhao; Xue-Guang Zhang; Ning Xu
Journal:  Acta Histochem       Date:  2006-03-13       Impact factor: 2.479

Review 10.  The pathogenesis of oral lichen planus.

Authors:  P B Sugerman; N W Savage; L J Walsh; Z Z Zhao; X J Zhou; A Khan; G J Seymour; M Bigby
Journal:  Crit Rev Oral Biol Med       Date:  2002
View more
  10 in total

1.  Hypertrophic Lichen Planus with Histological Features of Squamous Cell Carcinoma Associated with Immune Checkpoint Blockade Therapy.

Authors:  Amir H Ameri; Ruth K Foreman; Priyanka Vedak; Steven Chen; David M Miller; Shadmehr Demehri
Journal:  Oncologist       Date:  2020-02-19

2.  Clinical and Histologic Features of Lichenoid Mucocutaneous Eruptions Due to Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Immunotherapy.

Authors:  Veronica J Shi; Nemanja Rodic; Scott Gettinger; Jonathan S Leventhal; Julia P Neckman; Michael Girardi; Marcus Bosenberg; Jennifer N Choi
Journal:  JAMA Dermatol       Date:  2016-10-01       Impact factor: 10.282

3.  Oral lichenoid reactions associated with anti-PD-1/PD-L1 therapies: clinicopathological findings.

Authors:  V Sibaud; C Eid; V R Belum; P Combemale; B Barres; L Lamant; L Mourey; C Gomez-Roca; C L Estilo; R Motzer; E Vigarios; M E Lacouture
Journal:  J Eur Acad Dermatol Venereol       Date:  2017-05-08       Impact factor: 6.166

Review 4.  Skin Manifestation Induced by Immune Checkpoint Inhibitors.

Authors:  Toshiyuki Yamamoto
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-05-10

Review 5.  Black pepper and its bioactive constituent piperine: promising therapeutic strategies for oral lichen planus.

Authors:  Jing-Ya Yang; Jing Zhang; Gang Zhou
Journal:  Inflammopharmacology       Date:  2018-10-20       Impact factor: 4.473

6.  Altered Autophagy-Associated Genes Expression in T Cells of Oral Lichen Planus Correlated with Clinical Features.

Authors:  Ya-Qin Tan; Jing Zhang; Ge-Fei Du; Rui Lu; Guan-Ying Chen; Gang Zhou
Journal:  Mediators Inflamm       Date:  2016-02-15       Impact factor: 4.711

7.  Salivary and Serum Interferon-Gamma/Interleukin-4 Ratio in Oral Lichen Planus Patients: A Systematic Review and Meta-Analysis.

Authors:  Hamid Reza Mozaffari; Maryam Molavi; Pia Lopez-Jornet; Masoud Sadeghi; Mohsen Safaei; Mohammad Moslem Imani; Roohollah Sharifi; Hedaiat Moradpoor; Amin Golshah; Ladan Jamshidy
Journal:  Medicina (Kaunas)       Date:  2019-06-08       Impact factor: 2.430

8.  The Tipped Balance of ILC1/ILC2 in Peripheral Blood of Oral Lichen Planus Is Related to Inflammatory Cytokines.

Authors:  Zi-Ming Wang; Jing Zhang; Fang Wang; Gang Zhou
Journal:  Front Cell Dev Biol       Date:  2022-01-31

9.  MicroRNA-155-IFN-γ Feedback Loop in CD4(+)T Cells of Erosive type Oral Lichen Planus.

Authors:  Jing-Yu Hu; Jing Zhang; Jing-Zhi Ma; Xue-Yi Liang; Guan-Ying Chen; Rui Lu; Ge-Fei Du; Gang Zhou
Journal:  Sci Rep       Date:  2015-11-23       Impact factor: 4.379

10.  T cell-derived exosomes induced macrophage inflammatory protein-1α/β drive the trafficking of CD8+ T cells in oral lichen planus.

Authors:  Jing-Ya Yang; Jing Zhang; Rui Lu; Ya-Qin Tan; Ge-Fei Du; Gang Zhou
Journal:  J Cell Mol Med       Date:  2020-10-27       Impact factor: 5.295

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.